• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

50岁及以下无前列腺癌中国男性的初始前列腺特异性抗原(PSA)水平及PSA速率的分布和特征:一项多中心研究

Distributions and characteristics of initial PSA and PSA velocity in Chinese men aged 50 years and younger without prostate cancer: a multi-center study.

作者信息

Yang Wenjun, Liu Sirong, Hu Cheng, Xie Keji, Wei Xinghua, Zeng Weiwei, Tang Ping

机构信息

Department of Urology, Guangzhou First People's Hospital, the Second Affiliated Hospital of South China University of Technology, Guangzhou, China.

出版信息

J BUON. 2019 Mar-Apr;24(2):832-837.

PMID:31128043
Abstract

PURPOSE

To analyze the distributions and characteristics of initial prostate-specific antigen (PSA) and PSA velocity in Chinese men aged 50 years and younger without prostate cancer.

METHODS

The initial PSA test of men aged 50 years and younger, taken from January 2008 to December 2018 in two medical centers, was retrospectively analyzed. Cases with prostate cancer were excluded. The distributions of initial PSA and PSA velocity, and the correlations between these two values were estimated. Kaplan-Meier and log-rank test were used to estimate significant difference on the risk of PSA≥2.5 ng/mL after initial PSA measurement, stratified by median initial PSA (0.6 ng/mL).

RESULTS

A total of 9461 men with non-prostate cancer were included in this study. The median initial PSA value was 0.7 ng/mL. A total of 853 men had their PSA measured two times or more and the median PSA velocity was 0.026 ng·mL-1·yr-1. There was no two-two direct correlation between initial PSA testing age, initial PSA, and PSA velocity. After a follow-up of up to 10 years from the baseline PSA test, the risk of PSA ≥ 2.5 ng/mL, stratified by median initial PSA (0.7 ng/mL), was significantly different (log-rank test, p<0.001).

CONCLUSION

More than 25% of the men aged ≤ 50 years should have regularly PSA screening based on current guidelines. However, the subsequent risk of being diagnosed with prostate cancer in these men is unknown. Men aged 50 years and younger with an initial PSA higher than the median (0.7 ng/mL) have a subsequent higher risk of abnormal PSA value.

摘要

目的

分析50岁及以下无前列腺癌中国男性的初始前列腺特异性抗原(PSA)及PSA速率的分布情况和特征。

方法

回顾性分析2008年1月至2018年12月在两个医疗中心进行的50岁及以下男性的初始PSA检测。排除前列腺癌患者。评估初始PSA和PSA速率的分布情况以及这两个值之间的相关性。采用Kaplan-Meier法和对数秩检验评估初始PSA测量后PSA≥2.5 ng/mL风险的显著差异,按初始PSA中位数(0.6 ng/mL)分层。

结果

本研究共纳入9461例非前列腺癌男性。初始PSA值中位数为0.7 ng/mL。共有853名男性进行了两次或以上的PSA检测,PSA速率中位数为0.026 ng·mL-1·yr-1。初始PSA检测年龄、初始PSA和PSA速率之间不存在两两直接相关性。从基线PSA检测开始随访长达10年后,按初始PSA中位数(0.7 ng/mL)分层,PSA≥2.5 ng/mL的风险存在显著差异(对数秩检验,p<0.001)。

结论

根据现行指南,超过25%的50岁及以下男性应定期进行PSA筛查。然而,这些男性随后被诊断为前列腺癌的风险尚不清楚。初始PSA高于中位数(0.7 ng/mL)的50岁及以下男性,其后续PSA值异常的风险更高。

相似文献

1
Distributions and characteristics of initial PSA and PSA velocity in Chinese men aged 50 years and younger without prostate cancer: a multi-center study.50岁及以下无前列腺癌中国男性的初始前列腺特异性抗原(PSA)水平及PSA速率的分布和特征:一项多中心研究
J BUON. 2019 Mar-Apr;24(2):832-837.
2
Baseline prostate-specific antigen compared with median prostate-specific antigen for age group as predictor of prostate cancer risk in men younger than 60 years old.将年龄组的基线前列腺特异性抗原与中位前列腺特异性抗原进行比较,以此作为60岁以下男性前列腺癌风险的预测指标。
Urology. 2006 Feb;67(2):316-20. doi: 10.1016/j.urology.2005.08.040. Epub 2006 Jan 25.
3
Longitudinal PSA changes in men with and without prostate cancer: assessment of prostate cancer risk.患有和未患前列腺癌男性的前列腺特异性抗原(PSA)纵向变化:前列腺癌风险评估
Prostate. 2005 Aug 1;64(3):240-5. doi: 10.1002/pros.20210.
4
Free/total PSA ratio is a powerful predictor of future prostate cancer morbidity in men with initial PSA levels of 4.1 to 10.0 ng/mL.游离/总前列腺特异性抗原比值是初始前列腺特异性抗原水平为4.1至10.0纳克/毫升的男性未来前列腺癌发病率的有力预测指标。
Urology. 2003 Apr;61(4):760-4. doi: 10.1016/s0090-4295(02)02427-5.
5
Prostate-specific antigen change in the European Randomized Study of Screening for Prostate Cancer, section Rotterdam.欧洲前列腺癌筛查随机研究鹿特丹分部中前列腺特异性抗原的变化
Urology. 2004 Feb;63(2):316-20. doi: 10.1016/j.urology.2003.09.028.
6
Pretreatment PSA velocity and risk of death from prostate cancer following external beam radiation therapy.外照射放疗前前列腺特异性抗原(PSA)变化率与前列腺癌死亡风险
JAMA. 2005 Jul 27;294(4):440-7. doi: 10.1001/jama.294.4.440.
7
Diagnostic value of percent free prostate-specific antigen: retrospective analysis of a population-based screening study with emphasis on men with PSA levels less than 3.0 ng/mL.游离前列腺特异性抗原百分比的诊断价值:一项基于人群的筛查研究的回顾性分析,重点关注前列腺特异性抗原水平低于3.0 ng/mL的男性。
Urology. 1999 May;53(5):945-50. doi: 10.1016/s0090-4295(98)00640-2.
8
Prostate-specific antigen 'velocity' as a diagnostic test for prostate cancer.前列腺特异性抗原“速率”作为前列腺癌的诊断检测方法。
J Investig Med. 2006 Nov;54(7):361-4. doi: 10.2310/6650.2006.06003.
9
Usefulness of prostate-specific antigen velocity in screening for prostate cancer.前列腺特异性抗原速度在前列腺癌筛查中的效用。
Int J Urol. 2002 Jun;9(6):316-21. doi: 10.1046/j.1442-2042.2002.00466.x.
10
Predictors of subsequent prostate cancer in men with a prostate specific antigen of 2.6 to 4.0 ng/ml and an initially negative biopsy.前列腺特异性抗原为2.6至4.0 ng/ml且初次活检结果为阴性的男性后续发生前列腺癌的预测因素
J Urol. 2005 Aug;174(2):500-4. doi: 10.1097/01.ju.0000165203.40973.0f.

引用本文的文献

1
Clinical efficacy of prostate PI-RADS V2.1 score combined with serum PSA-related indicators in the detection of gray zone prostate cancer.前列腺 PI-RADS V2.1 评分联合血清 PSA 相关指标在灰区前列腺癌检测中的临床效能。
Int Urol Nephrol. 2023 Nov;55(11):2685-2693. doi: 10.1007/s11255-023-03692-0. Epub 2023 Jul 31.